Picture of Divi's Laboratories logo

DIVISLAB — Divi's Laboratories Cashflow Statement

0.000.00%
in flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

Annual cashflow statement for Divi's Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

2022
March 31st
2023
March 31st
2024
March 31st
2025
March 31st
2026
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IAS
IAS
IAS
IAS
IAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line36,83523,68621,63029,16033,880
Depreciation
Non-Cash Items-718-1,982-2,970-2,870-3,500
Unusual Items
Other Non-Cash Items
Changes in Working Capital-20,114-538-9,830-13,780-7,630
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities19,11824,59712,61016,53027,380
Capital Expenditures-7,132-4,730-10,030-14,380-25,200
Purchase of Fixed Assets
Other Investing Cash Flow Items-14,817-22,3467,3406,3403,010
Sale of Fixed Assets
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-21,949-27,076-2,690-8,040-22,190
Financing Cash Flow Items-3.6-3.3-20-20-50
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Debt
Cash from Financing Activities-5,324-7,972-7,990-7,990-8,040
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-8,156-10,4511,930500-2,850